Global Botulinum Toxins Market Size Will Reach $59.33 Billion in 2024

According?to?Global?Market?Monitor,?the?global botulinum toxins market size will reach $59.33 billion in 2024 with a CAGR of 9.67% from 2024 to 2029.

North America Dominates the Market.

North America held the largest market share – 51.27% in 2023. According to the American Society of Plastic Surgeons (ASPS), a million surgeries are performed with botulinum toxin products. Thus, increasing the use of botulinum toxin products in various cosmetic procedures performed in the region will stimulate the North American botulinum toxin industry growth.

Related Market Research Report: Global Botulinum Toxins Market Professional Research Report 2019-2030, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

By Regions:

North America

• United States
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Italy
• Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
• Spain
• Belgium
• Poland
• Russia
• Turkey
• Others

Asia-Pacific

• China
• Japan
• India
• South Korea
• Australia and New Zealand
• ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

• GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
• Brazil
• Nigeria
• South Africa
• Argentina
• Others

To?Learn?More?About?This?Report,?Request?a?Sample?Copy:https://www.globalmarketmonitor.com/reports/614371-botulinum-toxins-market-report.html

Asia Pacific will witness significant growth owing to favorable reimbursement, a large patient population, and the availability of developed healthcare facilities in many countries. In countries, like South Korea, China, and Japan, there is higher beauty consciousness and aesthetic awareness, hence likely to drive the market growth. Furthermore, there is a rising number of medical spas and cosmetic centers in countries like Thailand, Singapore, and Malaysia. These are the factors that are expected to drive the botulinum toxin sector in the region.

The increasing usage of botulinum toxin injection in several aesthetic procedures including treating glabellar lines, chemical brow lifts, forehead lines, and others is expected to boost the botulinum toxin industry growth over the coming years. Rising investment in R&D programs by major manufacturers to explore the therapeutic use of botulinum toxin is building opportunities to expand its therapeutic application area shortly. Minimally invasive procedures offer advantages such as smaller incisions, shorter hospital stays, quick outpatient services, rapid wound healing, lesser pain, and lower risk of complications than invasive surgeries.

Allergan plc is one of the major players operating in the Botulinum Toxins market, holding a share of 67.58% in 2023. Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women’s health, and anti-infective therapeutic products.

By Players:

• Allergan
• US WorldMeds
• Medytox
• Ipsen
• Merz
• LIBP

Access?Complete?Report?Description,?TOC,?Figures?&?Chart@https://www.globalmarketmonitor.com/reports/614371-botulinum-toxins-market-report.html

Table of Contents

1 Report Overview

• 1.1 Product Definition and Scope
• 1.2 PEST (Political, Economic, Social and Technological) Analysis of Botulinum Toxins Market
• 1.3 Market Segmentation by Type
• 1.4 Market Segmentation by End-Users
• 1.5 Market Segmentation by Regions

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics
• 2.2 Competitive Landscape Analysis

3 Segmentation of Botulinum Toxins Market by Types

• 3.1 Product Development Trends of Different Types
• 3.2 Commercial Product Types of Major Vendors
• 3.3 Competitive Landscape Analysis of Different Types
• 3.4 Market Size of Botulinum Toxins by Major Types

4 Segmentation of Botulinum Toxins Market by End-Users

• 4.1 Downstream Client Analysis by End-Users
• 4.2 Competitive Landscape Analysis of Different End-Users
• 4.3 Market Potential Analysis of Different End-Users
• 4.4 Market Size of Botulinum Toxins by Major End-Users

5 Market Analysis by Major Regions

• 5.1 Global Botulinum Toxins Production Analysis by Major Regions
• 5.2 Global Botulinum Toxins Consumption Analysis by Major Regions
• 5.3 Global Botulinum Toxins Production, Import, Consumption and Export Analysis by Regions

6 Product Commodity of Botulinum Toxins Market in Major Countries

• 6.1 Top 5 Export Countries in Botulinum Toxins market from 2014 to 2019
• 6.2 Top 5 Import Countries in Botulinum Toxins market from 2014 to 2019
• 6.3 Emerging Top 3 Export Countries Analysis
• 6.4 Emerging Top 3 Import Countries Analysis

7 North America Botulinum Toxins Landscape Analysis

• 7.1 North America Botulinum Toxins Landscape Analysis by Major Types
• 7.2 North America Botulinum Toxins Landscape Analysis by Major End-Users
• 7.3 North America Botulinum Toxins Landscape Analysis by Major Countries

8 Europe Botulinum Toxins Landscape Analysis

• 8.1 Europe Botulinum Toxins Landscape Analysis by Major Types
• 8.2 Europe Botulinum Toxins Landscape Analysis by Major End-Users
• 8.3 Europe Botulinum Toxins Landscape Analysis by Major Countries

9 Asia Pacific Botulinum Toxins Landscape Analysis

• 9.1 Asia Pacific Botulinum Toxins Landscape Analysis by Major Types
• 9.2 Asia Pacific Botulinum Toxins Landscape Analysis by Major End-Users
• 9.3 Asia Pacific Botulinum Toxins Landscape Analysis by Major Countries

10 Latin America, Middle East & Africa Botulinum Toxins Landscape Analysis

• 10.1 Latin America, Middle East & Africa Botulinum Toxins Landscape Analysis by Major Types
• 10.2 Latin America, Middle East & Africa Botulinum Toxins Landscape Analysis by Major End-Users
• 10.3 Latin America, Middle East & Africa Botulinum Toxins Landscape Analysis by Major Countries

11 Major Players Profile

• 11.1 Allergan
• 11.2 US WorldMeds
• 11.3 Medytox
• 11.4 Ipsen
• 11.5 Merz
• 11.6 LIBP

12 Data Source and Research Methodology